|
Conventional Neuroleptics
Citations 21-30 of 110 total displayed.
|
Past content
(since Dec 1998):
|
- Articles
Effectiveness of Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia After Discontinuing Perphenazine: A CATIE Study
- T. Scott Stroup, Jeffrey A. Lieberman, Joseph P. McEvoy, Marvin S. Swartz, Sonia M. Davis, George A. Capuano, Robert A. Rosenheck, Richard S.E. Keefe, Alexander L. Miller, Irving Belz, John K. Hsiao,, for the CATIE Investigators
Am J Psychiatry 2007; 164: 415-427.
[Abstract]
[Full text]
[PDF]
- Reviews and Overviews
Clinical Trial-Based Cost-Effectiveness Analyses of Antipsychotic Use
- Daniel Polsky, Jalpa A. Doshi, Mark S. Bauer, and Henry A. Glick
Am J Psychiatry 2006; 163: 2047-2056.
[Abstract]
[Full text]
[PDF]
- Articles
A Functional Magnetic Resonance Imaging Study of Social Cognition in Schizophrenia During an Acute Episode and After Recovery
- Kwang-Hyuk Lee, Wendy H. Brown, Paul N. Egleston, Russell D.J. Green, Tom F.D. Farrow, Michael D. Hunter, Randolph W. Parks, Iain D. Wilkinson, Sean A. Spence, and Peter W.R. Woodruff
Am J Psychiatry 2006; 163: 1926-1933.
[Abstract]
[Full text]
[PDF]
- Brief Reports
Reduced Thalamic Volume in Patients With Chronic Schizophrenia After Switching From Typical Antipsychotic Medications to Olanzapine
- Babak Khorram, Donna J. Lang, Lili C. Kopala, Robert A. Vandorpe, Qing Rui, Vina M. Goghari, Geoffrey N. Smith, and William G. Honer
Am J Psychiatry 2006; 163: 2005-2007.
[Abstract]
[Full text]
[PDF]
- Articles
Hyperlipidemia Following Treatment With Antipsychotic Medications
- Mark Olfson, Steven C. Marcus, Patricia Corey-Lisle, A.V. Tuomari, Patricia Hines, and Gilbert J. LItalien
Am J Psychiatry 2006; 163: 1821-1825.
[Abstract]
[Full text]
[PDF]
- Letters to the Editor
New-Onset Tardive Dyskinesia in Patients With First-Episode Psychosis Receiving Risperidone or Haloperidol
- GEORGES M. GHARABAWI, CYNTHIA A. BOSSIE, and YOUNG ZHU
Am J Psychiatry 2006; 163: 938-a-939-a.
[Full text]
[PDF]
- Articles
Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment
- Joseph P. McEvoy, Jeffrey A. Lieberman, T. Scott Stroup, Sonia M. Davis, Herbert Y. Meltzer, Robert A. Rosenheck, Marvin S. Swartz, Diana O. Perkins, Richard S.E. Keefe, Clarence E. Davis, Joanne Severe, John K. Hsiao, for the CATIE Investigators
Am J Psychiatry 2006; 163: 600-610.
[Abstract]
[Full text]
[PDF]
- Brief Reports
Time Course for Antipsychotic Treatment Response in First-Episode Schizophrenia
- Robin Emsley, Jonathan Rabinowitz, and Rossella Medori
Am J Psychiatry 2006; 163: 743-745.
[Abstract]
[Full text]
[PDF]
- Articles
Sildenafil in the Treatment of Antipsychotic-Induced Erectile Dysfunction: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose, Two-Way Crossover Trial
- Rajesh Gopalakrishnan, K.S. Jacob, Anju Kuruvilla, B. Vasantharaj, and Jacob K. John
Am J Psychiatry 2006; 163: 494-499.
[Abstract]
[Full text]
[PDF]
- Letters to the Editor
Neuroleptic Malignant Syndrome Related to a Switch to Perospirone and Anticholinergic Withdrawal
- HISASHI TANII, KOHEI FUJITA, and YUJI OKAZAKI
Am J Psychiatry 2006; 163: 547-b-548-b.
[Full text]
[PDF]
|
|